Edition:
India

Devik Jain

British midcaps post weekly losses on Brexit woes, dour outlook

27 Nov 2020

Domestically-oriented British midcap stocks rose slightly on Friday, but marked their first weekly loss this month as frictions in the Brexit process and a gloomy economic outlook due to the coronavirus weighed on sentiment.

UPDATE 2-British midcaps post weekly losses on Brexit woes, dour outlook

27 Nov 2020

* AstraZeneca to run new global trial of COVID-19 vaccine - report

London stocks end lower on grim post-lockdown outlook

26 Nov 2020

British stocks fell on Thursday amid heightened concerns over economic growth after Health Minister Matt Hancock said more than a third of the population would remain under tough COVID-19 restrictions at the end of a national lockdown.

UPDATE 2-London stocks end lower on grim post-lockdown outlook

26 Nov 2020

* Virgin Money drops for second straight day after profit slump

British stocks sink after Sunak underscores coronavirus woes

25 Nov 2020

British stocks came off vaccine-fuelled highs on Wednesday after Finance Minister Rishi Sunak flagged a major hit to economic growth from the coronavirus, prompting an index of domestically-exposed stocks to mark its worst tumble in nearly a month.

UPDATE 2-British stocks sink after Sunak underscores coronavirus woes

25 Nov 2020

* Publisher Future bottoms out midcap index (Updates to close)

London stocks end at multi-month highs on vaccine optimism, commodity gains

24 Nov 2020

Heavyweight commodity stocks pushed London's blue-chip index to a more than five-month closing high on Tuesday, while the midcap index ended at a near nine-month peak as optimism over a coronavirus vaccine increased hopes for a swift economic recovery.

UPDATE 2-London stocks end at multi-month highs on vaccine optimism, commodity gains

24 Nov 2020

* AO World slumps on anticipation of Brexit disruptions (Updates to close)

AstraZeneca vaccine news drags on FTSE, but mid-caps immune

23 Nov 2020

British stocks rose on optimism over a COVID-19 vaccine on Monday, although gains in the FTSE index were curbed by a fall in shares of AstraZeneca after the drugmaker's candidate was less effective than others in trials.

UPDATE 2-AstraZeneca vaccine news drags on FTSE, but mid-caps immune

23 Nov 2020

* Cineworld jumps on securing additional debt (Updates to close)

World News